Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Leukemia Research Reports is Scopus-indexed (Q3, CiteScore 1.6), WoS ESCI, DOAJ. Published by Elsevier Ltd.
Checked against the index lists dated .
ISSN 2213-0489Verify ISSN ↗
Publisher: Elsevier Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Hematology | 105 / 151 | 30th | Q3 |
| Oncology | 305 / 428 | 28th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2012–present, best quartile Q3, CiteScore 1.6.
Leukemia Research Reports is Q3 in Hematology (rank 105 of 151) and Q3 in Oncology (rank 305 of 428), by CiteScore 2025.
Leukemia Research Reports is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.6, which places it in quartile Q3 at the 30th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.332, quartile Q3, with an H-index of 18.
The publisher lists an article processing charge of about US$1,180 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Leukemia Research Reports is published by Elsevier Ltd. Its ISSN is 2213-0489.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Leukemia Research Reports has an h-index of 21 and a 2-year mean of 0.47 citations per paper (OpenAlex). Its Scopus CiteScore is 1.6, quartile Q3. On 2-year citations it ranks #114 of 148 Scopus journals in Hematology.
Leukemia Research Reports published 60 papers in 2025; its busiest recent year was 2024 with 84. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 94 research articles (2025–2026), authors are most often from China (20.2%), United States (14.4%) and Japan (10.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 3 retracted papers are recorded (5 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.